If CAP-1002 (Deramiocel) is approved on schedule, deramiocel would become the first therapy indicated specifically for DMD-associated cardiomyopathy, addressing a critical unmet need. The StealthX(tm) exosome delivery system is a momentous change.
The weekend saw major developments in the cryptocurrency world, including Ripple's concerns over the UK's crypto regulations, Circle's plans for a $5 billion IPO, Anthony Pompliano's praise for Trump's tariffs as a catalyst for crypto, and expectations of a Bitcoin price surge following potential monetary easing by the Fed.
